Live Breaking News & Updates on Achilles Therapeutics Daily

Stay updated with breaking news from Achilles therapeutics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Achilles Therapeutics plc (NASDAQ:ACHL) Short Interest Down 42.5% in May

Achilles Therapeutics plc (NASDAQ:ACHL – Get Free Report) was the target of a large decline in short interest in May. As of May 15th, there was short interest totalling 13,800 shares, a decline of 42.5% from the April 30th total of 24,000 shares. Approximately 0.0% of the shares of the stock are sold short. Based […] ....

Piper-sandler , Fcpm-iii-services , Nasdaq , Acadian-asset-management , Ikarian-capital , Achilles-therapeutics , Get-free-report , Point-capital , Asset-management , Vestal-point-capital , Achilles-therapeutics-daily ,

Short Interest in Achilles Therapeutics plc (NASDAQ:ACHL) Drops By 42.5%

Achilles Therapeutics plc (NASDAQ:ACHL – Get Free Report) saw a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 13,800 shares, a drop of 42.5% from the April 30th total of 24,000 shares. Based on an average daily trading volume, of 396,500 shares, the short-interest […] ....

Piper-sandler , Ikarian-capital , Nasdaq , Acadian-asset-management , Fcpm-iii-services , Achilles-therapeutics-company-profile , Achilles-therapeutics , Get-free-report , Point-capital , Asset-management , Achilles-therapeutics-daily ,

Contrasting Achilles Therapeutics (NASDAQ:ACHL) & Entera Bio (NASDAQ:ENTX)

Contrasting Achilles Therapeutics (NASDAQ:ACHL) & Entera Bio (NASDAQ:ENTX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Israel , London , City-of , United-kingdom , Jerusalem , Israel-general , Amgen-inc , Achilles-therapeutics-plc , Entera-bio-ltd , Achilles-therapeutics , Get-free-report

Achilles Therapeutics (NASDAQ:ACHL) PT Lowered to $6.00

Achilles Therapeutics (NASDAQ:ACHL – Free Report) had its target price reduced by Chardan Capital from $11.00 to $6.00 in a research report released on Friday, Benzinga reports. They currently have a buy rating on the stock. Other research analysts also recently issued reports about the company. Piper Sandler reissued a neutral rating and issued a […] ....

United-states , America , Piper-sandler , Fcpm-iii-services , Blackrock-inc , Achilles-therapeutics-plc , Citadel-advisors , Renaissance-technologies , Achilles-therapeutics , Free-report , Chardan-capital , Vestal-point-capital

Achilles Therapeutics (NASDAQ:ACHL) Earns "Neutral" Rating from Piper Sandler

Achilles Therapeutics (NASDAQ:ACHL) Earns "Neutral" Rating from Piper Sandler
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Piper-sandler , Sei-investments-co , Achilles-therapeutics-plc , Achilles-therapeutics-company-profile , Virtu-financial , America-corp , Balyasny-asset-management , Renaissance-technologies , Achilles-therapeutics , Free-report